Table 6.
Comparisons between survivor and non-survivor in CrKP sepsis and COVID-19 sepsis.
| Variables | Survivors |
Non-survivors |
||||
|---|---|---|---|---|---|---|
| CrKP (n = 38) | COVID-19 (n = 94) | p value | CrKP (n = 25) | COVID-19 (n = 13) | p value | |
| Age (years) | 61.5 (15.9) | 56.9 (14.5) | 0.170 | 57.4 (20.4) | 67.5 (16.7) | 0.161 |
| ≤60 | 18 (47.4) | 51 (54.3) | 0.565 | 14 (56.0) | 3 (23.1) | 0.086 |
| >60 | 20 (52.6) | 43 (45.7) | 0.565 | 11 (44.0) | 10 (76.9) | 0.086 |
| Comorbidities | 29 (76.3) | 41 (43.6) | <0.001 | 6 (24.0) | 5 (38.5) | 0.080 |
| Lymphocyte (1 × 109/L) | 1.0 (0.8–2.0) | 0.9 (0.6–1.2) | 0.025 | 0.9 (0.6–1.5) | 0.5 (0.4–0.9) | 0.014 |
| ≤0.5 | 3 (7.9) | 16 (17.0) | 0.274 | 4 (16.0) | 6 (46.2) | 0.062 |
| 0.6–1.0 | 17 (44.7) | 45 (47.9) | 0.284 | 11 (44.0) | 6 (46.2) | 1000 |
| ≥1.1 | 18 (47.4) | 33 (35.1) | 0.237 | 10 (40.0) | 1 (7.7) | 0.057 |
| Neutrophils (1 × 109/L) | 8.6 (6.8–11.0) | 4.5 (3.2–7.1) | <0.001 | (5.8–14.9) | 7.7 (3.7–8.8) | 0.202 |
| <3.9 | 5 (13.2) | 37 (39.4) | 0.004 | 5 (20.0) | 4 (30.8) | 0.689 |
| 3.9–6.3 | 3 (7.9) | 28 (29.8) | 0.011 | 3 (12.0) | 1 (7.7) | 1.000 |
| >6.3 | 30 (79.0) | 29 (30.9) | <0.001 | 17 (68.0) | 8 (61.5) | 0.730 |
| Platelets (1 × 109/L) | 226.8 (111.1) | 190.7 (59.6) | <0.001 | 160.3 (101.0) | 175.2 (51.2) | 0.303 |
| >150 | 2 (5.3) | 5 (5.3) | 0.999 | 8 (32.0) | 1 (7.7) | 0.126 |
| 100-150 | 7 (18.4) | 17 (18.1) | 0.999 | 4 (16.0) | 2 (15.4) | 1.000 |
| <100 | 29 (76.3) | 72 (76.6) | 0.999 | 13 (52.0) | 10 (76.9) | 0.176 |
| PaO2/FiO2 | 311.30 (86.8) | 245.1 (109.1) | 0.007 | 288.0 (131.1) | 209.9 (65.3) | 0.281 |
| >300 | 22 (57.9) | 14 (38.9) | 0.112 | 12 (48.0) | 0 (0.0) | 0.238 |
| 200-300 | 12 (31.6) | 4 (11.1) | 0.048 | 8 (32.0) | 2 (66.7) | 0.284 |
| <200 | 4 (10.5) | 18 (50.0) | <0.001 | 5 (20.0) | 1 (33.3) | 0.530 |
| Corticosteroid therapy | 19 (50.0) | 74 (78.7) | 0.001 | 5 (20.0) | 10 (76.9) | 0.001 |
Data are expressed as n (%) or median (IQR).